- Home
- RYI vs EYPT Comparison
RYI vs EYPT Comparison
Compare RYI & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYI
- EYPT
- Stock Information
- Founded
- RYI 1842
- EYPT 1987
- Country
- RYI United States
- EYPT United States
- Employees
- RYI N/A
- EYPT N/A
- Industry
- RYI Metal Fabrications
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- RYI Industrials
- EYPT Industrials
- Exchange
- RYI Nasdaq
- EYPT Nasdaq
- Market Cap
- RYI 661.1M
- EYPT 489.4M
- IPO Year
- RYI N/A
- EYPT 2005
- Fundamental
- Price
- RYI $21.56
- EYPT $7.69
- Analyst Decision
- RYI Hold
- EYPT Strong Buy
- Analyst Count
- RYI 1
- EYPT 8
- Target Price
- RYI $28.00
- EYPT $25.71
- AVG Volume (30 Days)
- RYI 279.1K
- EYPT 665.0K
- Earning Date
- RYI 02-20-2025
- EYPT 03-06-2025
- Dividend Yield
- RYI 3.42%
- EYPT N/A
- EPS Growth
- RYI N/A
- EYPT N/A
- EPS
- RYI 0.64
- EYPT N/A
- Revenue
- RYI $4,703,700,000.00
- EYPT $45,713,000.00
- Revenue This Year
- RYI N/A
- EYPT N/A
- Revenue Next Year
- RYI $1.76
- EYPT N/A
- P/E Ratio
- RYI $33.54
- EYPT N/A
- Revenue Growth
- RYI N/A
- EYPT 7.50
- 52 Week Low
- RYI $17.18
- EYPT $6.90
- 52 Week High
- RYI $36.15
- EYPT $30.99
- Technical
- Relative Strength Index (RSI)
- RYI 52.23
- EYPT 41.66
- Support Level
- RYI $21.17
- EYPT $7.58
- Resistance Level
- RYI $23.50
- EYPT $8.16
- Average True Range (ATR)
- RYI 0.83
- EYPT 0.55
- MACD
- RYI 0.32
- EYPT -0.07
- Stochastic Oscillator
- RYI 47.80
- EYPT 3.06
About RYI Ryerson Holding Corporation
Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. Its customers range from local, independently owned fabricators and machine shops to large, international original equipment manufacturers. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company generates substantially all of its revenue from sales of metal products. Geographically, the majority is from the United States.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.